Release Date: 12/11/09 16:50 Summary: Response to ASX Query - Appendix 4C Price Sensitive: No Download Document 123.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%